NYSE · Health Care · Medical Devices
ABT
Abbott Laboratories
Sells diagnostics and continuous glucose monitors alongside medical devices and nutrition brands such as infant formula.
$111.25-0.02%
Close · 2026-08-14$80$90$100$110$120$130
NovFebMayAug
$81.39
$134.3852-week range, last close at 56% of the range
- 1W
- +3.19%
- 1M
- +24.62%
- 3M
- +32.64%
- 6M
- +0.06%
- YTD
- -9.56%
- 1Y
- -11.96%
- Avg vol 20d
- 9.1M
- RVOL
- 0.61
- HOLD band
Fundamentalsas of 2026-08-14
- Mkt cap
- $192.51B
- P/E
- 36.0
- Fwd P/E
- 18.3
- EPS
- $3.09
- Div yield
- 2.27%
- Beta
- 0.58
- Employees
- 122K
- Next earnings
- 2026-10-14
Rating & verdict historyoldest → newest
100.0% correct+0.75% avg moveBUY 0/0 · HOLD 1/1 · SELL 0/0
| Date | Call | Outcome | Return | Takeaway |
|---|---|---|---|---|
| 2026-08-14 | Subscribers | — | — | Subscribe to read |
| 2026-08-13 | Subscribers | — | — | Subscribe to read |
| 2026-08-12 | Subscribers | — | — | Subscribe to read |
| 2026-08-11 | Subscribers | — | — | Subscribe to read |
| 2026-08-10 | Subscribers |